Aligning industry incentives with AMR control goals: Exploring the feasibility of an antibiotic susceptibility bonus for drugs to treat Gram-negative infection
Aligning industry incentives with AMR control goals: Exploring the feasibility of an antibiotic susceptibility bonus for drugs to treat Gram-negative infection
将行业激励措施与抗菌素耐药性控制目标结合起来：探索治疗革兰氏阴性感染药物的抗生素敏感性奖金的可行性
批准号：
367922
负责人：
Hollis Aidan
金额：
$11.05万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-07-01 至 2019-07-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
High prices create incentives for industry to develop new antibiotics, but also incentivize firms to promote their products to maximize sales volume. Similarly, the Market Entry Rewards proposed by the O'Neill Commission and others will, if introduced, he
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alternatives and Supplements to Patents for Pharmaceutical Innovation: A Multidisciplinary Exploration of Alternatives
-
批准号：209047
-
项目类别：Operating Grants
-
资助金额：$0.97万
-
财政年份：2010
-
负责人：Hollis Aidan
-
依托单位：
海外基金
